{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:51:05Z","timestamp":1790913065791,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Toxicologic Pathology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.etp.2008.11.004","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T11:27:03Z","timestamp":1231414023000},"page":"537-552","source":"Crossref","is-referenced-by-count":47,"title":["The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis \u2013 A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide"],"prefix":"10.1016","volume":"61","author":[{"given":"T.","family":"Steger-Hartmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Raschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Riefke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.etp.2008.11.004_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2133.2007.08335.x","article-title":"Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis","volume":"158","author":"Abraham","year":"2008","journal-title":"Brit J Dermatol"},{"issue":"2","key":"10.1016\/j.etp.2008.11.004_bib2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2214\/AJR.06.1094","article-title":"Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned","volume":"188","author":"Broome","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.etp.2008.11.004_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacr.2007.08.016","article-title":"Circulating fibrocytes: cellular basis for NSF","volume":"5","author":"Bucala","year":"2008","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"10.1016\/j.etp.2008.11.004_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.etp.2008.11.004_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","article-title":"Nephrogenic fibrosing dermopathy: the first 6 years","volume":"15","author":"Cowper","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.etp.2008.11.004_bib5","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.etp.2008.11.004_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/path.2311","article-title":"Gadodiamide contrast agent activates fibroblasts: a possible cause of nephrogenic systemic fibrosis","volume":"214","author":"Edward","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.etp.2008.11.004_bib8","unstructured":"Frenzel T. Stability and dissociation of gadolinium-complexes in human serum. In: European congress of radiology, Vienna. Abstract B-095, Session SS206a, 2008."},{"issue":"2","key":"10.1016\/j.etp.2008.11.004_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200319190","article-title":"Osteopontin: a bridge between bone and the immune system","volume":"112","author":"Gravallese","year":"2003","journal-title":"J Clin Invest"},{"issue":"Suppl. 1","key":"10.1016\/j.etp.2008.11.004_bib10","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/00004424-199303001-00004","article-title":"Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent","volume":"28","author":"Harpur","year":"1993","journal-title":"Invest Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/jn\/118.12.1586","article-title":"Tumor necrosis factor-mediated hypoalbuminemia in rabbits","volume":"8","author":"Hennig","year":"1988","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.etp.2008.11.004_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemi disease","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.etp.2008.11.004_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2008.03.012","article-title":"Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review","volume":"248","author":"Id\u00e9e","year":"2008","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.etp.2008.11.004_bib15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2008.02.038","article-title":"Nephrogenic systemic fibrosis is associated with transforming growth factor \u00df and Smad without evidence of renin\u2013angiotensin system involvement","volume":"58","author":"Kelly","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.etp.2008.11.004_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.rli.0000253505.88945.d5","article-title":"Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan)","volume":"42","author":"Khurana","year":"2007","journal-title":"Invest Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1378\/chest.06-2751","article-title":"Stem cells for lung disease","volume":"132","author":"Loebinger","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.etp.2008.11.004_bib18","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.etp.2008.11.004_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00495978","article-title":"Demonstration of phosphates in calcium deposits: a modification of von Kossa's reaction","volume":"56","author":"Puchtler","year":"1978","journal-title":"Histochemistry"},{"key":"10.1016\/j.etp.2008.11.004_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s007950200009","article-title":"Cellular and molecular events leading to renal tubulointerstitial fibrosis","volume":"35","author":"Razzaque","year":"2002","journal-title":"Med Electron Microsc"},{"key":"10.1016\/j.etp.2008.11.004_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","article-title":"Nephrogenic systemic fibrosis: risk factors and incidence estimation","volume":"243","author":"Sadowski","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.etp.2008.11.004_bib22","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","article-title":"Osteopontin\u2014a multifunctional molecule regulating chronic inflammation and vascular disease","volume":"11","author":"Scatena","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.etp.2008.11.004_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/RLI.0b013e31815e6277","article-title":"A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media","volume":"43","author":"Sieber","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jmri.21368","article-title":"Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand","volume":"27","author":"Sieber","year":"2008","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.etp.2008.11.004_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-008-0977-y","article-title":"Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions","author":"Sieber","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib26","doi-asserted-by":"crossref","unstructured":"Speer MY, McKee MD, Guldberg RE, Liaw L, Karsenty G, Yang HY, et al. Osteopontin, an inducible inhibitor of vascular calcification on matix GLA protein-deficient mice. In: Third international conference on osteopontin and sibling, 2002.","DOI":"10.1100\/tsw.2002.244"},{"key":"10.1016\/j.etp.2008.11.004_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.jcbfm.9600055","article-title":"Monocyte chemoattractant protein-1 regulation of blood-protein barrier permeability","volume":"25","author":"Stamatovic","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1016\/j.etp.2008.11.004_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.rli.0000208223.34203.49","article-title":"Preclinical safety assessment of Vasovist (gadofosveset trisodium): a new magnetic resonance imaging contrast agent for angiography","volume":"41","author":"Steger-Hartmann","year":"2006","journal-title":"Invest Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib30","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.2007060645","article-title":"New insights into nephrogenic systemic fibrosis","volume":"18","author":"Swaminathan","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.etp.2008.11.004_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-145-3-200608010-00021","article-title":"Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy","volume":"145","author":"Swaminathan","year":"2004","journal-title":"Ann Inter Med"},{"issue":"12","key":"10.1016\/j.etp.2008.11.004_bib31","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s00330-006-0495-8","article-title":"Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide","volume":"16","author":"Thomsen","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.etp.2008.11.004_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.pharmtox.48.113006.094615","article-title":"Biomarkers of acute kidney injury","volume":"48","author":"Vaidya","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.etp.2008.11.004_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00004424-200107000-00006","article-title":"Toxicological assessment of gadoversetamide injection (Optimark), a new contrast-enhancement agent for use in magnetic resonance imaging","volume":"36","author":"Wible","year":"2001","journal-title":"Invest Radiol"}],"container-title":["Experimental and Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299308001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0940299308001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T03:12:26Z","timestamp":1558062746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0940299308001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0940299308001772"],"URL":"https:\/\/doi.org\/10.1016\/j.etp.2008.11.004","relation":{},"ISSN":["0940-2993"],"issn-type":[{"value":"0940-2993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}